[ad_1]

Company Logo

Dublin, May 20, 2022 (GLOBE NEWSWIRE) — The “Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s providing.

The international senolytic medicine market is anticipated to develop at a major fee in the course of the forecast interval with market progress attributed to the rising calls for for anti-aging therapeutics and prescription drugs.

Advances in pharmaceutical medicine and the rising want for wholesome lifespan are accelerating the expansion of the worldwide senolytic medicine market. Senescence is a situation or course of the place cell ages and completely cease dividing however doesn’t die. In a while, these cells can begin accumulating and kind a tumor or the event of most cancers.

The organic course of may lead to weaker eyesight, pores and skin wrinkling, lesser listening to capability, and many others. Senolytic medicine are designed to focus on the senescent cells and destroy them with their results.

Increasing demand for anti-aging medicine and pharmaceutical merchandise to extend the lifespan of human beings are anticipated to drive the expansion of the senolytic medicine market. According to the U.N. Economic and Social Affairs statistics, the variety of individuals aged 65 years and above is anticipated to develop by 120% and attain round 1.5 billion by 2050.

Thus, the rising geriatric inhabitants throughout the globe is anticipated to propel the expansion of the worldwide senolytic medicine market. Moreover, the rising incidences of age-related problems like cataracts, glaucoma, neurodegenerative ailments, cardiovascular ailments, pulmonary infections, and many others., and sedentary life-style among the many international inhabitants are driving the expansion of the worldwide senolytic medicine market.

The emergence of superior applied sciences, from gene remedy to stem cells, and ongoing analysis actions for innovation in pharmaceutical medicine are anticipated to gas the expansion of the worldwide senolytic medicine market. Accelerating demand for enhancing and optimizing personalised and preventive care is additional driving the expansion of the worldwide senolytic medicine market.

Based on software, the worldwide senolytic medicine market is split into longevity, senescence inhibition, cardiovascular ailments, neural degenerative ailments, and others. The longevity section is anticipated to dominate the market within the coming years due to the quickly rising geriatric inhabitants and rising demand for pharmaceutical merchandise aiding the wholesome lifespan of people.

Major gamers working within the international senolytic medicine market are AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc, and many others.

Story continues

Objective of the Study:

To analyze the historic progress out there dimension of worldwide senolytic medicine market from 2017 to 2021

To estimate and forecast the market dimension of worldwide senolytic medicine market from 2022E to 2027F and progress fee till 2027F

To classify and forecast international senolytic medicine market primarily based on sort, software, distribution channel, area, and aggressive Landscape

To determine dominant area or section within the international senolytic medicine market

To determine drivers and challenges for international senolytic medicine market

To look at aggressive developments equivalent to expansions, new product launches, mergers & acquisitions, and many others, in international senolytic medicine market

To determine and analyze the profile of main gamers working in international senolytic medicine market

To determine key sustainable methods adopted by market gamers in international senolytic medicine market

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Senolytic Drugs Market

5. Voice of Customer
5.1. Preference, By Type
5.2. Factors Contributing to Demand for Senolytic Drugs
5.3. Barriers to Adoption of Senolytic Drugs
5.4. Brand Awareness

6. Clinical Trials
6.1. Ongoing Clinical Trials
6.2. Completed Clinical Trials
6.3. Terminated Clinical Trials
6.4. Clinical Trial Analysis

7. Patent Analysis
7.1. Patent Granted (2016-2020)
7.2. Patent Applications Filed

8. Global Senolytic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others)
8.2.2. By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others)
8.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
8.2.4. By Company (2021)
8.2.5. By Region
8.3. Product Market Map

9. North America Senolytic Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Senolytic Drugs Market Outlook
9.3.2. Mexico Senolytic Drugs Market Outlook
9.3.3. Canada Senolytic Drugs Market Outlook

10. Europe Senolytic Drugs Market Outlook

11. Asia-Pacific Senolytic Drugs Market Outlook

12. South America Senolytic Drugs Market Outlook

13. Middle East and Africa Senolytic Drugs Market Outlook

14. Market Dynamics
14.1. Drivers
14.2. Challenges

15. Market Trends & Developments

16. Competitive Landscape
16.1. AgeX Therapeutics, Inc.
16.2. Cleara Biotech
16.3. Eternans Ltd.
16.4. FoxBio Inc
16.5. Numeric Biotech
16.6. T.A. Sciences, Inc.
16.7. Recursion Pharmaceuticals, Inc.

For extra details about this report go to https://www.researchandmarkets.com/r/a9jdto

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

[ad_2]

Source link

#Voice #Customer #Clinical #Trials #Patent #Analysis #Outlook #Market #Dynamics #Trends #Developments #Competitive #Landscape

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published.